On the recordNovember 13, 2023
Will the publication of phase three clinical trial results with that last month all signs point toward MDMA assisted therapy receiving FDA approval within the next year.
Source
congress.govEditor's note · Context
Bergman expresses optimism about MDMA therapy's potential FDA approval.
Share & report
More from Jack Bergman
Dec 11, 2023
We need to put the money where we are going to get the results for our veterans.
Mar 21, 2024
Mr. Chairman, I am here today to offer my amendment to H.R. 7023. Michigan's First District is home to more than 2,000 miles of Great Lakes coastline. It is by far the most of any congressional district, and it touches three of the five…
Apr 30, 2024
Mr. Speaker, I thank my friend and colleague from northern Minnesota for yielding. We share a lot of commonalities, and one is our love of the outdoors and of our national treasures. Mr. Speaker, I rise in favor today of H.R. 3195, the…
Jun 4, 2024
Mr. Chair, this amendment would urge the Veterans Administration to make a decision on incorporating MDMA-assisted therapy into their formulary within 180 days of FDA approval. This is based on legislation by the gentleman from Wisconsin…
Other voices in this conversation
